mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.02 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.03 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |